Comparison of chemoradiotherapy with radiotherapy alone for “biopsy only” anaplastic astrocytoma | Zendy

Jing Wu | Zendy; Ting Zou | Zendy; Harrison X. Bai | Zendy; Xuejun Li | Zendy; Zishu Zhang | Zendy; Bo Xiao | Zendy; MacLean P. Nasrallah | Zendy; Giorgos C. Karakousis | Zendy; Ya Cao | Zendy; Paul J. Zhang | Zendy; Li Yang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of chemoradiotherapy with radiotherapy alone for “biopsy only” anaplastic astrocytoma

Author(s) -

Jing Wu,

Ting Zou,

Harrison X. Bai,

Xuejun Li,

Zishu Zhang,

Bo Xiao,

MacLean P. Nasrallah,

Giorgos C. Karakousis,

Ya Cao,

Paul J. Zhang,

Li Yang

Publication year - 2017

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.17441

Subject(s) - medicine , chemoradiotherapy , radiation therapy , anaplastic astrocytoma , neurosurgery , oncology , biopsy , astrocytoma , glioma , surgery , cancer research

It has become increasingly common to incorporate adjuvant chemotherapy with radiotherapy in the treatment of resected anaplastic astrocytoma based on results from recent phase II/III randomized trials. However, whether or not combined chemoradiotherapy is associated with improved survival outcome in patients who undergo "biopsy only" is less clear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research